Evidence map›Paper›PMID 40085439›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2025

Sustained activation induced cytidine deaminase (AID) expression in B cells following Plasmodium falciparum malaria infection in Kenyan children.

Bonface Ariera, Bernard Guyah, Jeremy Rahkola, Ian Arao, Kevin Waomba, Emmily Koech, Gabriela Samayoa-Reyes, Katherine R Sabourin, Sidney Ogolla, Rosemary Rochford

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bonface ArieraCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Bernard GuyahDepartment of Biomedical Sciences and Technology, Maseno University, Maseno, Kenya.
Jeremy RahkolaRocky Mountain Regional Veterans Affairs (VA) Medical Center, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Ian AraoCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Kevin WaombaCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.ORCID 0009-0000-3410-0198
Emmily KoechCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Gabriela Samayoa-ReyesDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Katherine R SabourinDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Sidney OgollaCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Rosemary RochfordDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

Funding

The synergistic contributions of EBV and malaria to the etiology of Burkitt lymphomaR01AI141531 · NIAID · UNIVERSITY OF COLORADO DENVER · PI SAMAYOA REYES, GABRIELA M · 2020 to 2024
$3.6M
Dr. Rosemary RochfordNational Institute of Allergy and Infectious DiseaseNIAID NIH HHS R01 AI141531NIH HHS RO1 AI141531
6 · The paper itself

Abstract

Burkitt lymphoma (BL) is characterized by elevated levels of the enzyme activation-induced cytidine deaminase (AID), an enzyme critical for MYC translocation that is the hallmark of BL. Both EBV and Plasmodium falciparum malaria are cofactors in the etiology of BL. However, how these 2 pathogens drive BL pathogenesis is not yet understood. In this study, we tested the hypothesis that P. falciparum and EBV synergize to induce dysregulated expression of AID. Using flow cytometry, intracellular AID expression was measured in PBMCs from a cohort of children from Western Kenya with uncomplicated malaria and community controls. Children with uncomplicated malaria had elevated levels of CD19+ AID+ B cells compared to controls. This high level of AID was sustained up to 8 weeks after parasite clearance. Using ImageStream flow cytometry, we found that 52% of AID was localized in the nucleus of CD19+ B cells in children with malaria. To test whether EBV and P. falciparum synergized to drive the expression of AID, we stimulated CD19+ B cells with EBV, CpG (to mimic P. falciparum DNA), or BAFF (induced during P. falciparum infection), or as a combination. Individually, EBV, BAFF and CpG induced AID expression. However, when combined, there was a significant increase of ∼30% in the frequency of CD19+AID+ cells above cells treated with EBV, BAFF, or CpG individually. Collectively, these data suggest that P. falciparum malaria and EBV coinfection result in sustained AID expression, potentially influencing the MYC translocation that is characteristic of BL.

Indexed as

B-LymphocytesBurkitt LymphomaCytidine DeaminaseEpstein-Barr Virus InfectionsMalaria, FalciparumPlasmodium falciparumAICDA (Activation-Induced Cytidine Deaminase)Antigens, CD19ChildChild, PreschoolCoinfectionFemaleHerpesvirus 4, HumanHumansInfantKenyaAICDA (Activation-Induced Cytidine Deaminase)Antigens, CD19Cytidine Deaminaseactivation-induced cytidine deaminaseBurkitt lymphomaEpstein-Barr virusKenyaPlasmodium falciparum malaria

Identifiers

PMID40085439
PMCPMC12123209

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.